Effects of adlay bran and its ethanolic extract and residue on preneoplastic lesions of the colon in rats

Journal of the Science of Food and Agriculture

Volumn 91, Issue 3, 2011, Pages 547-552

  Li, Sing Chung ^a   Chen, Chiao Ming ^b   Lin, Shu Hui ^a   Chiang, Wenchang ^c   Shih, Chun Kuang ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b SHIH CHIEN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Aberrant crypt foci; Adlay bran; Colon cancer; Mucin

Indexed keywords

MUCIN; PLANT EXTRACT;

ABERRANT CRYPT FOCUS; ANIMAL; ARTICLE; CEREAL; CHINA; COIX; COLON; COLON TUMOR; DOSE RESPONSE; DRUG EFFECT; FISCHER 344 RAT; MALE; METABOLISM; PATHOLOGY; RAT;

ABERRANT CRYPT FOCI; ANIMALS; CEREALS; CHINA; COIX; COLON; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MUCINS; PLANT EXTRACTS; RATS; RATS, INBRED F344;

COIX; COIX LACRYMA-JOBI; RATTUS;

EID: 78651062603     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.4219     Document Type: Article

References (37)

1. Normile D, The new face of traditional Chinese medicines. Science 299: 188-190 (2003).
2. Kuo C-C, Shih M-C, Kuo Y-H and Chiang W, Antagonism of free-radical-induced damage of adlay seed and its antiproliferative effect in human histolytic lymphoma U937 monocytic cells. J Agric Food Chem 49: 1564-1570 (2001).
3. Chang H-C, Huang Y-C and Hung W-C, Antiproliferative and chemopreventive effects of adlay seed on lung cancer in vitro and in vivo. J Agric Food Chem 51: 3656-3660 (2003).
4. 2/M arrest, and regulation of gene expression. J Gastroenterol Hepatol 20: 1046-1053 (2005).
5. Woo JH, Li D, Wilsbach K, Orita H, Coulter J, Tully E, et al, Coix seed extract, a common used treatment for cancer in China, inhibits NFkappaB and protein kinase C signaling. Cancer Biol Ther 6: 2005-2011 (2007).
6. Lee M-Y, Lin H-Y, Cheng F, Chiang W and Kuo Y-H, Isolation and characterization of new lactam compounds that inhibit lung and colon cancer cells from adlay (Coix lachryma-jobi L. var. ma-yuen Stapf) bran. Food Chem Toxicol 46: 1933-1939 (2008).
7. Lee M-Y, Tsai S-H, Kuo Y-H and Chiang W, Anti-tumor and anti-inflammatory activity of the methanol extracts from adlay bran. Food Sci Biotechnol 17: 1265-1271 (2008).
8. Tokuda H, Matsumoto T, Konoshima T, Kozuka M, Nishino H and Iwashima A, Inhibitory effects on Epstein-Barr virus activation and anti-tumor promoting activities of coix seed. Planta Med 56: 653-654 (1990).
9. Numata M, Yamamoto A, Moribayashi A and Yamada H, Antitumor components isolated from the Chinese herbal medicine Coix lachryma-jobi. Planta Med 60: 356-359 (1994).
10. Chiang W, Shyu M-L, Su J-P and Pang VF, Evaluation of the accessory anti-tumor effect of adlay processing food. J Health Sci 2: 113-122 (2000).
11. Shih C-K, Chiang W and Kuo M-L, Effects of adlay on azoxymethane-induced colon carcinogenesis in rats. Food Chem Toxicol 42: 1339-1347 (2004).
12. Parkin DM, Bray F, Ferlay J and Pisani P, Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108 (2005).
13. Tanaka T, Colorectal carcinogenesis: review of human and experimental animal studies. J Carcinogenesis 8: 5 (2009). DOI:10.4103/1477-3163.49014.
14. Einspahr JG, Alberts DS, Gapstur SM, Bostick RM, Emerson SS and Gerner EW, Surrogate end-point biomarkers as measures of colon cancer risk and their use in cancer chemoprevention trials. Cancer Epidemiol Biomarkers Prev 6: 37-48 (1997).
15. Gustin DM and Brenner DE, Chemoprevention of colon cancer: current status and future prospects. Cancer Metastasis Rev 21: 323-348 (2002).
16. Femia AP and Caderni G, Rodent models of colon carcinogenesis for the study of chemopreventive activity of natural products. Planta Med 74: 1602-1607 (2008).
17. Bird RP and Good CK, The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett 112/113: 395-402 (2000).
18. Hegazi RAF, Saad RS, Mady H, Matarese LE, O'Keefe S and Kandil HM, Dietary fatty acids modulate chronic colitis, colitis-associated colon neoplasia and COX-2 expression in IL-10 knockout mice. Nutrition 22: 275-282 (2006).
19. Narayansingh R and Hurta RAR, Cranberry extract and quercetin modulate the expression of cyclooxygenase-2 (COX-2) and IκBα in human colon cancer cells. J Sci Food Agric 89: 542-547 (2008).
20. Itzkowitz SH and Yio X, Inflammation and cancer. IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 287: G7-G17 (2004).
21. Takahashi M and Wakabayashi K, Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci 95: 475-480 (2004).
22. Wu T-T, Charles AL and Huang T-C, Determination of the contents of the main biochemical compounds of adlay (Coix lachryma-jobi). Food Chem 104: 1509-1515 (2007).
23. AOAC, Official Methods of Analysis (13th edn). Association of Official Analytical Chemists, Washington, DC (1980).
24. Prosky L, Asp NG, Schmeizer TF, DeVries JW and Furda I, Determination of insoluble, soluble, and total dietary fiber in foods and food products: interlaboratory study. J Assoc Off Anal Chem 71: 1017-1023 (1988).
25. Reeves PG, Nielsen FH and Fahey GC, AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J Nutr 123: 1939-1951 (1993).
26. Bird RP, Aberrant crypt foci system to study cancer preventive agents in the colon, in Tumor Marker Protocols, ed. by Hanausek M and Walaszek Z. Humana Press, Totowa, pp. 465-474 (1998).
27. Caderni G, Giannini A, Lancioni L, Luceri C, Biggeri A and Dolara P, Characterization of aberrant crypt foci in carcinogen-treated rats: association with intestinal carcinogenesis. Br J Cancer 71: 763-769 (1995).
28. Caderni G, Femia AP, Giannini A, Favuzza A, Luceri C, Salvadori M, et al, Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis. Cancer Res 63: 2388-2392 (2003).
29. Jenab M, Chen J-M and Thompson LU, Siaolomucin production in aberrant crypt foci relates to degree of dysplasia and rate of cell proliferation. Cancer Lett 165: 19-25 (2001).
30. Tsukamoto T, Kozaki K-I, Nishikawa Y, Yamamoto M, Fukami H, Inoue M, et al, Development and distribution of 2-amino-1-methyl-6-phenylimidazo [4, 5-b]-pyridine (PhIP)-induced aberrant crypt foci in the rat large intestine. Jpn J Cancer Res 90: 720-725 (1999).
31. Jenab M and Thompson LU, The influence of phytic acid in wheat bran on early biomarkers of colon carcinogenesis. Carcinogenesis 19: 1087-1092 (1998).
32. Uchida K, Kado S, Ando M, Nagata Y, Takagi A and Onoue M, A mucinous histochemical study on malignancy of aberrant crypt foci (ACF) in rat colon. J Vet Med Sci 63: 145-149 (2001).
33. Femia AP, Bendinelli B, Giannini A, Salvadori M, Pinzani P, Dolara P, et al, Mucin-depleted foci have beta-catenin gene mutations, altered expression of its protein, and are dose- and time-dependent in the colon of 1, 2-dimethylhydrazine-treated rats. Int J Cancer 116: 9-15 (2005).
34. Femia AP, Dolara P, Servili M, Esposto S, Taticchi A, Urbani S, et al, No effects of olive oils with different phenolic content compared to corn oil on 1, 2-dimethylhydrazine-induced colon carcinogenesis in rats. Eur J Nutr 47: 329-334 (2008).
35. Tanimura A, Studies on the anti-tumor component in the seeds of Coix lachryma-jobi L. var. ma-yuen (Roman.) Stapf. II. The structure of coixenolide. Chem Pharmaceut Bull 9: 47-53 (1961).
36. Banik KB, Becker FF and Banik I, Synthesis of anticancer β-lactams: mechanism of action. Bioorgan Med Chem 12: 2523-2528 (2004).
37. 2+-treated low-density lipoprotein (LDL) oxidation and lipopolysaccharide (LPS)-induced inflammation in RAW 264.7 macrophages. J Agric Food Chem 57: 2259-2266 (2009).